Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Hemab Therapeutics Holdings, Inc. (COAG) had Return on Investments of -5.32% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-24.15M |
|
-- |
|
-- |
|
$26.08M |
|
$-26.08M |
|
$2.03M |
|
$-24.05M |
|
$-24.05M |
|
$-24.15M |
|
$-24.15M |
|
$-24.15M |
|
$-24.15M |
|
$-26.08M |
|
$-26.00M |
|
30.11M |
|
30.11M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$464.00M |
|
$0.60M |
|
$3.78M |
|
$467.78M |
|
$12.94M |
|
-- |
|
$0.57M |
|
$13.51M |
|
$454.27M |
|
$454.27M |
|
$454.27M |
|
46.71M |
|
| Cash Flow Statement Financials | |
$-44.22M |
|
$-123.28M |
|
$317.12M |
|
$87.97M |
|
$237.37M |
|
$149.39M |
|
$3.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.32% |
|
-5.32% |
|
-5.16% |
|
|
Return on Investments |
-5.32% |
$9.73 |
|
$-1.47 |
|
$-1.47 |
|